Company
A list of companies that distribute hepatitis C treatments. This list is by no means comprehensive, it is for people who are seeking treatment to get some idea of what kinds of medications are available. Find the treatment that you think will work for you, but be sure to consult a doctor before making any dessions.
Zadaxin thymosin alpha 1 (thymalfasin), is a safe and effective treatment for chronic hepatitis B when used alone or in combination with interferon. Primary research indicates that Zadaxin may be useful in treating a number of other diseases as well, including hepatitis C, non-small cell lung cancer, melanoma, and HIV/AIDS. In addition, Zadaxin is also indicated as a vaccine adjuvant, to enhance the effectiveness of influenza and hepatitis B vaccines. Viral hepatitis B and C, diseases that afflict more than 500 million people worldwide, may lead to the development of liver cancer and cirrhosis.
Pegasys is a form of interferon treatment—a substance that has been shown to help fight hepatitis C. It is used alone or in combination with Copegus (Ribavirin, USP) in adults with compensated liver disease not previously treated with interferon alpha. Hepatitis C treatment with Pegasys provides a response within 24 or 48 weeks (depending on the type of your hepatitis C virus).
Pegintron combination therapy has been proven to be more effective than standard non-pegylated interferon in treating chronic hepatitis C. That means Pegintron combination therapy provides you with a better chance of clearing the virus from your body.
Roferon-A (Interferon alfa-2a, recombinant) is a sterile protein product for use by injection. Roferon-A is manufactured by recombinant DNA technology that employs a genetically engineered Escherichia coli bacterium containing DNA that codes for the human protein. Interferon alfa-2a, recombinant is a highly purified protein containing 165 amino acids, and it has an approximate molecular weight of 19,000 daltons
Intron A (interferon alfa-2b, recomninant) for injection is indicated as adjuvant to surgical treatment in patients 18 years of age or older with malignant melanoma who ater free ot disease but at tigh fisk for systemic recuuence within 56 days of srugery.
Rebetol is an antiviral medication.
Rebetol must be used together with an interferon alfa product (such as Peg-Intron or Intron A) to treat chronic hepatitis C. Rebetol is not effective when used alone to treat hepatitis C. Rebetol must be used together with an interferon alfa product (such as Peg-Intron or Intron A) to treat chronic hepatitis C.